IBC
Return of Research Results to Study Participants
Research into participant experiences has consistently shown their desire to learn the results of research to which they’ve contributed.
Patient Recruitment and Enrollment in Clinical Trials
Learn more about patient recruitment and enrollment: how they find out about clinical trials and the reasons they participate.
A Checklist for Optimizing Clinical Trial Study Startup Activities
This checklist outlines key milestones and considerations for sites and sponsors in the clinical trial study startup process.
Becoming Your Own Best Advocate Through Patient Empowerment
In this episode, we discuss clinical trial patient empowerment and advocacy. We dive into health literacy and the informed consent process.
Clinical Trial Superheroes
Download this eBook to learn about the individuals who dedicate their talents to give patients an opportunity for healthier and longer lives.
mRNA Clinical Trials: Key Regulatory Considerations
Responses to the most frequently asked questions regarding mRNA technology and clinical trial regulatory requirements.
A Journey in Support of Diversity
Advarra's Sergio Armani introduces ACRP's Ride for Diversity program and why it's important to him personally and to the research community.
Gene Therapy Ready Site Network
This info sheet describes Advarra’s Gene Therapy Ready site network and the benefits of joining the network.
Advarra’s Support for Institutions
Find out how we keep site centricity at the forefront through our technology, services, and extraordinary team members.
Holiday Schedule – Presidents’ Day (US) and Family Day (Canada)
Advarra's US and Canada offices will be closed on February 21, 2022 due to the Presidents' Day and Family Day holidays.
Beginner’s Guide to Community-Based Participatory Research
Learn what CBPR is, how it's employed, the benefits of conducting it, & how to best approach this type of research.
ABSA International Appoints Advarra Executive Daniel Eisenman as Scientific Program Committee Co-Chair
The American Biological Safety Association International appointed Advarra's Daniel Eisenman as co-chair of its Scientific Program Committee.